Selective packaging of cellular miRNAs in HIV-1 particles

Virus Research

Volumn 169, Issue 2, 2012, Pages 438-447

  Schopman, Nick C T ^a   van Montfort, Thijs ^a   Willemsen, Marcel ^a   Knoepfel, Stefanie A ^a   Pollakis, Georgios ^a   van Kampen, Antoine ^a,b   Sanders, Rogier W ^a,c   Haasnoot, Joost ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Deep sequencing; HIV 1; MiRNA; RNA interference; Virion

Indexed keywords

MICRORNA; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL COMPONENT; CELL DIFFERENTIATION; DIFFERENTIATION; GENE DOSAGE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE BINDING SITE; PACKAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION; VIRION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION;

CELLS, CULTURED; HIV-1; HUMANS; MICRORNAS; SEQUENCE ANALYSIS; T-LYMPHOCYTES; VIRION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84868616533     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.06.017     Document Type: Article

References (59)

1. Ahluwalia J.K., et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008, 5:117.
2. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
3. Andersson M.G., Haasnoot P.C.J., Xu N., Berenjian S., Berkhout B., Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. Journal of Virology 2005, 79:9556-9565.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Bennasser Y., Le S.Y., Benkirane M., Jeang K.T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005, 22:607-619.
7. Berkhout B., Jeang K.T. RISCy business: MicroRNAs, pathogenesis, and viruses. Journal of Biological Chemistry 2007, 282:26641-26645.
8. Berkowitz R., Fisher J., Goff S.P. RNA packaging. Current Topics in Microbiology and Immunology 1996, 214:177-218.
9. Bignami F., et al. Stable changes in CD4+ T-lymphocyte microRNA expression following exposure to HIV-1. Blood 2012.
10. Buck A.H., Perot J., Chisholm M.A., Kumar D.S., Tuddenham L., Cognat V., Marcinowski L., Dolken L., Pfeffer S. Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 2010, 16:307-315.
11. Cameron P.U., Handley A.J., Baylis D.C., Solomon A.E., Bernard N., Purcell D.F., Lewin S.R. Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes. Journal of Virology 2007, 81:2297-2306.
12. Cavrois M., Neidleman J., Kreisberg J.F., Greene W.C. In vitro derived dendritic cells trans-infect CD4T cells primarily with surface-bound HIV-1 virions. PLoS Pathogens 2007, 3:e4.
13. Cordey S., Junier T., Gerlach D., Gobbini F., Farinelli L., Zdobnov E.M., Winther B., Tapparel C., Kaiser L. Rhinovirus genome evolution during experimental human infection. PLoS ONE 2010, 5:e10588.
14. Crist R.M., Datta S.A., Stephen A.G., Soheilian F., Mirro J., Fisher R.J., Nagashima K., Rein A. Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly. Journal of Virology 2009, 83:2216-2225.
15. Das A.T., Klaver B., Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). Journal of Virology 1995, 69:3090-3097.
16. Das A.T., Klaver B., Berkhout B. Sequence variation of the HIV primer-binding site suggests the use of an alternative tRNALys molecule in reverse transcription. Journal of General Virology 1997, 78:837-840.
17. Das A.T., Vink M., Berkhout B. Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity. Journal of Virology 2005, 79:3179-3181.
18. Didierlaurent L., Racine P.J., Houzet L., Chamontin C., Berkhout B., Mougel M. Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles. Nucleic Acids Research 2011.
19. Fang L., et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011, 30:806-821.
20. Gagliardi M.C., Sallusto F., Marinaro M., Langenkamp A., Lanzavecchia A., De Magistris M.T. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. European Journal of Immunology 2000, 30:2394-2403.
21. Ganesh L., Leung K., Lore K., Levin R., Panet A., Schwartz O., Koup R.A., Nabel G.J. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. Journal of Virology 2004, 78:11980-11987.
22. Gibbings D.J., Ciaudo C., Erhardt M., Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nature Cell Biology 2009, 11:1143-1149.
23. Hariharan M., Scaria V., Pillai B., Brahmachari S.K. Targets for human encoded microRNAs in HIV genes. Biochemical and Biophysical Research Communications 2005, 337:1214-1218.
24. Hayes A.M., Qian S., Yu L., Boris-Lawrie K. Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. Retrovirology 2011, 8:36.
25. Henke J.I., Goergen D., Zheng J., Song Y., Schuttler C.G., Fehr C., Junemann C., Niepmann M. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO Journal 2008, 27:3300-3310.
26. Houzet L., Yeung M.L., de L.V., Desai D., Smith S.M., Jeang K.T. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 2008, 5:118.
27. Huang J., Wang F., Argyris E., Chen K., Liang Z., Tian H., Huang W., Squires K., Verlinghieri G., Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes. Nature Medicine 2007, 13:1241-1247.
28. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
29. Jopling C.L. Regulation of hepatitis C virus by microRNA-122. Biochemical Society Transactions 2008, 36:1220-1223.
30. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005, 309:1577-1581.
31. Kang J.G., Majerciak V., Uldrick T.S., Wang X., Kruhlak M., Yarchoan R., Zheng Z.M. Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. Journal of Pathology 2011, 225:378-389.
32. Keene S.E., King S.R., Telesnitsky A. 7SL RNA is retained in HIV-1 minimal virus-like particles as an S-domain fragment. Journal of Virology 2010, 84:9070-9077.
33. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 2005, 6:376-385.
34. Kincaid R.P., Burke J.M., Sullivan C.S. RNA virus microRNA that mimics a B-cell oncomiR. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:3077-3082.
35. Kleiman L. tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1. IUBMB Life 2002, 53:107-114.
36. Kleiman L., Caudry S., Boulerice F., Wainberg M.A., Parniak M.A. Incorporation of tRNA into normal and mutant HIV-1. Biochemical and Biophysical Research Communications 1991, 174:1272-1280.
37. Mak J., Jiang M., Wainberg M.A., Hammarskjold M.L., Rekosh D., Kleiman L. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. Journal of Virology 1994, 68:2065-2072.
38. Nakamura S., et al. Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. PLoS ONE 2009, 4:e4219.
39. Nathans R., Chu C.Y., Serquina A.K., Lu C.C., Cao H., Rana T.M. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Molecular Cell 2009, 34:696-709.
40. ELI. Virology 1991, 185:661-672.
41. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., de Gruijl T.D., Wurdinger T., Middeldorp J.M. Functional delivery of viral miRNAs via exosomes. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:6328-6333.
42. Riley K.J., Rabinowitz G.S., Yario T.A., Luna J.M., Darnell R.B., Steitz J.A. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO Journal 2012, 31:2207-2221.
43. Roush S., Slack F.J. The let-7 family of microRNAs. Trends in Cell Biology 2008, 18:505-516.
44. Routh A., Domitrovic T., Johnson J.E. Host RNAs, including transposons, are encapsidated by a eukaryotic single-stranded RNA virus. Proceedings of the National Academy of Sciences of the United States of America 2012.
45. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine 1994, 179:1109-1118.
46. Santhakumar D., et al. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13830-13835.
47. Schnettler E., de V.W., Hemmes H., Haasnoot J., Kormelink R., Goldbach R., Berkhout B. The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Reports 2009, 10:258-263.
48. Schopman N.C., Heynen S., Haasnoot J., Berkhout B. A miRNA-tRNA mix-up: tRNA origin of proposed miRNA. RNA Biology 2010, 7.
49. Schopman N.C., Ter Brake O., Berkhout B. Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010, 7:52.
50. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Molecular Cell 2010, 38:323-332.
51. Skalsky R.L., et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathogens 2012, 8:e1002484.
52. Triboulet R., et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315:1579-1582.
53. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007, 9:654-659.
54. van Montfort T., Nabatov A.A., Geijtenbeek T.B., Pollakis G., Paxton W.A. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. Journal of Immunology 2007, 178:3177-3185.
55. Vasilatou D., Papageorgiou S., Pappa V., Papageorgiou E., Dervenoulas J. The role of microRNAs in normal and malignant hematopoiesis. European Journal of Haematology 2010, 84:1-16.
56. Wang C., Mitsuya Y., Gharizadeh B., Ronaghi M., Shafer R.W. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Research 2007, 17:1195-1201.
57. Witwer K.W., Watson A.K., Blankson J.N., Clements J.E. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 2012, 9:5.
58. Wright C.F., Morelli M.J., Thebaud G., Knowles N.J., Herzyk P., Paton D.J., Haydon D.T., King D.P. Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. Journal of Virology 2011, 85:2266-2275.
59. Zhang W., Du J., Yu K., Wang T., Yong X., Yu X.F. Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions. Journal of Virology 2010, 84:12903-12913.